Adefovir Dipivoxil Tablets (Dinghe) 10?mg Low price wholesale

Adefovir Dipivoxil Tablets (Dinghe) 10?mg Low price wholesale

$2.00

Adefovir Dipivoxil Tablets (Dinghe) contain 10?mg of the prodrug per tablet, sold in boxes of 14. Produced by Chongxin Pharmaceutical and approved under China NMPA H20080034. Designed strictly for preclinical and laboratory research. Wholesale and retail supported.?Please consult staff for other specifications and uses?

EMI starting from $0.00/month - View Plans
Compare

描述

Adefovir Dipivoxil is an acyclic nucleotide analog prodrug of adefovir, functioning as a reverse transcriptase inhibitor—widely used in hepatitis B research. Each tablet delivers 10?mg of active compound. Manufactured by Chia?Tian Chongxin Pharmaceutical (Dinghe), approved under NMPA registration number H20080034, with drug code 86904127003695 and barcode 6937861350224.

Ideal for in vitro or in vivo studies of antiviral mechanisms, viral drug resistance, and nucleoside analog pharmacodynamics. Not for clinical, diagnostic, or veterinary use—research use only.


Adefovir Dipivoxil Tablets Product Specifications

Parameter Details
Product Name Adefovir Dipivoxil Tablets (Dinghe)
Generic Name Adefovir Dipivoxil
CAS Number 142340?99?6
Molecular Formula C??H??N?O?P
Molecular Weight 501.47?Da
Dosage Form Film-coated tablet
Strength 10?mg per tablet
Quantity 14 tablets per box
Approval Number China NMPA H20080034
Product Code 86904127003695
Manufacturer Chongxin Pharmaceutical Co., Ltd.
Barcode 6937861350224
Intended Use Laboratory research only
Storage Store sealed at room temperature below 30?°C

Adefovir Dipivoxil Tablets Mechanism & Research Applications

Adefovir Dipivoxil is a prodrug converted intracellularly to adefovir diphosphate, which inhibits hepatitis B virus polymerase by competing with natural deoxyadenosine triphosphate, causing DNA chain termination. It’s used extensively in research to study:

  • HBV inhibition and viral replication kinetics

  • Drug-resistance mutations and antiviral resilience

  • Combination therapies and HBV polymerase function

  • Pharmacokinetic and pharmacodynamic profiling in preclinical models


Adefovir Dipivoxil Tablets Safety & Handling

  • Use: Strictly for laboratory research; not for human or veterinary administration

  • Storage: Keep sealed and store below 30?°C

  • Handling: Use PPE—lab coat, gloves, safety glasses

  • Disposal: Follow institutional hazardous waste protocols


Core Keywords

Adefovir dipivoxil tablets, Dinghe antiviral tablet, 10?mg adefovir dipivoxil, HBV research compound, nucleotide analog for lab use, NMPA H20080034 adefovir, Chongxin adefovir dipivoxil, bulk antiviral research tablet, lab-grade reverse transcriptase inhibitor, hepatitis B prodrug research


Research Use Disclaimer

This product is exclusively for laboratory research use and is not approved for clinical, therapeutic, diagnostic, or veterinary purposes. Improper use may pose health risks. Always adhere to institutional biosafety and local regulations.

其他信息

重量 1.3 公斤
尺寸 34 × 32 × 34 厘米

评价

目前还没有评价

成为第一个“Adefovir Dipivoxil Tablets (Dinghe) 10?mg Low price wholesale” 的评价者

您的邮箱地址不会被公开。 必填项已用 * 标注

Q1: Is this tablet suitable for therapeutic use?

A1: No. It is strictly for laboratory research only, not approved for clinical or veterinary use.

Q2: Can I buy in bulk?

A2: Yes. We offer both wholesale and retail ordering, with global shipping capabilities.

Q3: Are COA and SDS documents available?

A3: Yes. We provide Certificate of Analysis and Safety Data Sheet upon request.

Q4: What is the mechanism of action?

A4: Intracellular conversion to adefovir diphosphate, which inhibits HBV DNA polymerase by chain termination

Q5: What are typical research applications?

A5: Primarily used in chronic HBV research, drug resistance studies, polymerase function assays, and preclinical antiviral testing.


EMI Options

Select at least 2 products
to compare